Science Translational Medicine · 2021 · 220 citations · 27 references
MedicineOncologyPharmaceuticsDiagnostic ImagingDrug DeliveryNeuro-oncologyBrain MetastasesBrain MetastasisBrain TumorsImage-guided TherapyTargeted Cancer TherapyTherapeutic Monoclonal AntibodiesFocus Ultrasound-mediated Bbb DisruptionHer2-positive Metastatic DiseaseImage-guided Cancer TherapyMonoclonal Antibody InfusionTargeted Delivery Across The Blood-brain BarrierTherapeutic Antibody Delivery To The BrainTumor Tissue TargetingTumor-targeted Drug Delivery
In-BzDTPA-NLS-trastuzumab SPECT imaging. The standardized uptake value ratio (SUVR) of MRgFUS-treated lesions increased, on average, by 101 ± 71%, compared to −18 ± 26% in control lesions. MRgFUS enhanced drug uptake in 87 ± 17% of sonicated voxels (>20% increase in SUVR), with up to a 450% voxel-wise increase detected. Control lesions had 8 ± 8% voxels with >20% increase in SUVR. With treatment, unidimensional tumor measurements decreased by 19 ± 12%. This study provides first-in-human evidence of noninvasive, spatially targeted monoclonal antibody delivery across the BBB using MRgFUS, demonstrating the promise of this technology for a broad range of CNS diseases.
27
Blood–brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound
Nir Lipsman, Ying Meng, Allison Bethune et al. · Nature Communications · 2018 · 941 citations · Full text
Medicine, Neurology, Neuroscience +17